Intercept Pharmaceuticals Inc. said its liver drug received conditional approval from the European Commission to treat patients with primary biliary cholangitis (PBC).
Siemens Healthineers plans to invest approximately $300 million into its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility to increase its manufacturing footprint in the United States.
INC Research Holdings, a contract research organization, is planning a $37.9 million investment as the company shifts from Raleigh to a new Morrisville, N.C. headquarters. The move to a larger facility will create an additional 550 jobs over the next several years, the company said.
Two leading U.S. medical societies are poised to issue new diabetes treatment guidelines that are expected to reflect the lifesaving cardiovascular effects of Eli Lilly’s Jardiance.
U.S. researchers have found evidence of the Zika virus replicating in fetal brains for up to seven months after the mother became infected with the virus, and they showed the virus can persist even after birth, according to a published study.
Veterans with posttraumatic stress disorder (PTSD) who have difficulties making it to in-person therapy sessions may be able to get treatment that is just as good by videoconference.
Bristol-Myers Squibb Company announced important changes to its U.S. geographic footprint that will strengthen capabilities of the company’s R&D hubs of world-class science and innovation in Central New Jersey, the San Francisco Bay Area and Cambridge, Massachusetts while further integrating biologics development with clinical manufacturing at key sites to foster greater speed and collaboration.
Eli Lilly and Co. said certain patients using its insulin products via a partnership with Express Scripts Holding Co. could secure a discount of up to 40 percent.
The global pharmaceuticals industry is set to win the lowest annual number of new drug approvals in 2016 since 2010.